These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25853764)

  • 1. PML in a patient without severe lymphocytopenia receiving dimethyl fumarate.
    Nieuwkamp DJ; Murk JL; van Oosten BW; Cremers CH; Killestein J; Viveen MC; Van Hecke W; Frijlink DW; Wattjes MP;
    N Engl J Med; 2015 Apr; 372(15):1474-6. PubMed ID: 25853764
    [No Abstract]   [Full Text] [Related]  

  • 2. PML in a patient with lymphocytopenia treated with dimethyl fumarate.
    Rosenkranz T; Novas M; Terborg C
    N Engl J Med; 2015 Apr; 372(15):1476-8. PubMed ID: 25853765
    [No Abstract]   [Full Text] [Related]  

  • 3. PML in Patients Treated with Dimethyl Fumarate.
    van Kester MS; Bouwes Bavinck JN; Quint KD
    N Engl J Med; 2015 Aug; 373(6):583-4. PubMed ID: 26244326
    [No Abstract]   [Full Text] [Related]  

  • 4. PML in Patients Treated with Dimethyl Fumarate.
    Nieuwkamp DJ; Murk JL; van Oosten BW
    N Engl J Med; 2015 Aug; 373(6):584. PubMed ID: 26244324
    [No Abstract]   [Full Text] [Related]  

  • 5. PML in Patients Treated with Dimethyl Fumarate.
    Balak D; Hajdarbegovic E
    N Engl J Med; 2015 Aug; 373(6):582-3. PubMed ID: 26244325
    [No Abstract]   [Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients.
    Balak DMW; Hajdarbegovic E; Bramer WM; Neumann HAM; Thio HB
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1475-1482. PubMed ID: 28322482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More on PML in Patients Treated with Dimethyl Fumarate.
    Reich K; Hartung HP; Lebwohl M
    N Engl J Med; 2016 Jan; 374(3):294-5. PubMed ID: 26789900
    [No Abstract]   [Full Text] [Related]  

  • 8. More on PML in Patients Treated with Dimethyl Fumarate. Author reply.
    Murk JL; Nieuwkamp DJ; van Oosten BW
    N Engl J Med; 2016 Jan; 374(3):296. PubMed ID: 26798868
    [No Abstract]   [Full Text] [Related]  

  • 9. More on PML in Patients Treated with Dimethyl Fumarate. Author reply.
    van Kester MS; Bouwes Bavinck JN; Quint KD
    N Engl J Med; 2016 Jan; 374(3):295-6. PubMed ID: 26798867
    [No Abstract]   [Full Text] [Related]  

  • 10. More on PML in Patients Treated with Dimethyl Fumarate. Author reply.
    Balak D; Hajdarbegovic E
    N Engl J Med; 2016 Jan; 374(3):295. PubMed ID: 26789899
    [No Abstract]   [Full Text] [Related]  

  • 11. PML in a patient treated with dimethyl fumarate from a compounding pharmacy.
    van Oosten BW; Killestein J; Barkhof F; Polman CH; Wattjes MP
    N Engl J Med; 2013 Apr; 368(17):1658-9. PubMed ID: 23614604
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate.
    Bartsch T; Rempe T; Wrede A; Leypoldt F; Brück W; Adams O; Rohr A; Jansen O; Wüthrich C; Deuschl G; Koralnik IJ
    Ann Neurol; 2015 Oct; 78(4):501-14. PubMed ID: 26150206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis.
    Stoppe M; Thomä E; Liebert UG; Major EO; Hoffmann KT; Claßen J; Then Bergh F
    J Neurol; 2014 May; 261(5):1021-4. PubMed ID: 24638202
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanding spectrum of opportunistic infections associated with dimethyl fumarate.
    Kim T; Croteau D; Brinker A; Jones DE; Lee PR; Kortepeter CM
    Mult Scler; 2021 Jul; 27(8):1301-1305. PubMed ID: 33300850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML in a patient treated with fumaric acid.
    Ermis U; Weis J; Schulz JB
    N Engl J Med; 2013 Apr; 368(17):1657-8. PubMed ID: 23614603
    [No Abstract]   [Full Text] [Related]  

  • 16. Progressive multifocal leucoencephalopathy and psoriasis.
    Molloy OE; Foley CC; Lally A; Moriarty B; Collins P; O'Gorman J; de Gascun CF; Kirby B
    Br J Dermatol; 2017 Jul; 177(1):271-272. PubMed ID: 27589678
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion.
    Garcia J; Hendel-Chavez H; De-Goer MG; L'Honneur AS; Dubessy AL; Taoufik Y; Stankoff B
    Mult Scler; 2021 Apr; 27(4):640-644. PubMed ID: 32686582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescence.
    Diebold M; Altersberger V; Décard BF; Kappos L; Derfuss T; Lorscheider J
    Mult Scler; 2019 Oct; 25(12):1682-1685. PubMed ID: 31208265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy.
    Ladizinski B; Heller MM; Bhutani T; Zitelli KB; Koo JY
    J Drugs Dermatol; 2013 Feb; 12(2):e20-4. PubMed ID: 23377400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients.
    Jordan AL; Yang J; Fisher CJ; Racke MK; Mao-Draayer Y
    Mult Scler; 2022 Jan; 28(1):7-15. PubMed ID: 32808554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.